A Fatal Case of Necrotizing Fasciitis Caused by Serratia marcescens

Curtis, Christopher E.; Chock, Stefan; Henderson, Terrance; Holman, Michael J.
March 2005
American Surgeon;Mar2005, Vol. 71 Issue 3, p228
Academic Journal
A patient with a history of type II diabetes mellitus (DM), end stage renal disease (ESRD), and congestive heart failure (CHF) developed necrotizing fasciitis caused by Serratia marcescens after scraping his leg on rocks in a river while fishing. Aggressive management with surgical debridement, antibiotics, and pressure support was unsuccessful.


Related Articles

  • Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus. Cherney, David Z.I.; Repetto, Enrico; Wheeler, David C.; Arnold, Suzanne V.; MacLachlan, Sharon; Hunt, Philip R.; Chen, Hungta; Vora, Jiten; Kosiborod, Mikhail; Cherney, David Z I; Wheeler, David C; Arnold, Suzanne V; Hunt, Philip R // American Journal of Nephrology;Jan2020, Vol. 51 Issue 1, p74 

    Background: We evaluated the incremental contribution of chronic kidney disease (CKD) to the risk of major adverse cardiovascular (CV) events (MACE), heart failure (HF), and all-cause mortality (ACM) in type 2 diabetes mellitus (T2DM) patients and its importance relative to the...

  • Human histopathology of PASCAL laser burns. Paulus, Y M; Kaur, K; Egbert, P R; Blumenkranz, M S; Moshfeghi, D M // Eye;Aug2013, Vol. 27 Issue 8, p995 

    The article presents a case study of a 66-year-old male patient with type 2 diabetes, coronary artery disease, congestive heart failure, and chronic kidney disease who was admitted due to abdominal pain and hypoxia. It states that the case was the first reported human pathology of pattern...

  • A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients. Cheng, Li-Jen; Chen, Jeng-Huei; Lin, Ming-Yen; Chen, Li-Chia; Lao, Chun-Huan; Luh, Hsing; Hwang, Shang-Jyh // Scientific Reports;10/30/2015, p15687 

    This retrospective cohort study investigated the progression risk of sequential complication in Asian type 2 diabetes (T2D) patients using the Taiwan Pay-for-Performance Diabetes Registry and claim data from November 2003 to February 2009. 226,310 adult T2D patients without complication were...

  • Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney disease. Shivakumar, Oshini; Sattar, Naveed; Wheeler, David C // Nephrology Dialysis Transplantation;2020 Supplement, Vol. 35, pi43 

    Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular events, specifically those related to heart failure in patients with type 2 diabetes. Reductions in major adverse cardiovascular event (MACE) outcomes are also observed, but confined largely to patients who have prior...

  • Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review. Crowley, Matthew J; Diamantidis, Clarissa J; McDuffie, Jennifer R; Cameron, C Blake; Stanifer, John W; Mock, Clare K; Wang, Xianwei; Tang, Shuang; Nagi, Avishek; Kosinski, Andrzej S; Williams, John W Jr // Annals of Internal Medicine;1/3/2017, Vol. 166 Issue 1, pN.PAG 

    Background: Recent changes to the U.S. Food and Drug Administration boxed warning for metformin will increase its use in persons with historical contraindications or precautions. Prescribers must understand the clinical outcomes of metformin use in these populations.Purpose:...

  • CKD predicts mortality in diabetes.  // Clinical Advisor;Apr2012, Vol. 15 Issue 4, p20 

    The article reports on the result of a review of 22 randomized controlled trials which shows that chronic kidney disease (CKD) was associated with the highest mortality rates in diabetes.

  • Losartan reduces the burden and cost of ESRD: Public health implications from the RENAAL study for the European Union. Gerth, William C.; Remuzzi, Giuseppi; Viberti, Giancarlo; Hannedouche, Thierry; Martinez-Castelao, Alberto; Shahinfar, Shahnaz; Carides, George W.; Brenner, Barry // Kidney International Supplement;Dec2002, Issue 82, p68 

    Losartan reduces the burden and cost of ESRD: Public health implications from the RENAAL study for the European Union. Type 2 diabetes is the leading cause of end-stage renal disease (ESRD) in most industrialized countries in Europe. The RENAAL (Reduction of Endpoints in NIDDM with the...

  • Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk. Lim, Wai H.; Johnson, David W.; Hawley, Carmel; Lok, Charmaine; Polkinghorne, Kevan R.; Roberts, Matthew A.; Boudville, Neil; Wong, Germaine // Medical Journal of Australia;11/19/2018, Vol. 209 Issue 10, p440 

    Objectives: To examine the association between type 2 diabetes mellitus, with and without diabetic nephropathy, and cardiovascular disease-related mortality in dialysis-dependent patients with end-stage kidney disease (ESKD); to determine whether this association is affected by the...

  • New recommendations aim to reduce cardiovascular and renal risk in T2D.  // Practice Nurse;Jan2020, Vol. 50 Issue 1, p6 

    The article offers information on update of 2018 consensus report of American Diabetes Association and the European Association for the Study of Diabetes (ADA/EASD). It includes recommendations to treat high-risk patients with a GLP-1 receptor agonists (RAs) or SGLT2 inhibitor to reduce major...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics